Inotek Pharmaceuticals Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Inotek Pharmaceuticals Corp
TickerRCKT
CIK #0001281895
CUSIP77313F106
SectorLife Sciences - Pharmaceutical Preparations
Address131 Hartwell Ave 1St Floor, Suite 105, Lexington, MA 02421
Source [EDGAR]
CIK Filing 2011 - 2025
[0001281895] 10-K
[0001281895] 10-Q
[0001281895] 3
[0001281895] 4
[0001281895] 5
[0001281895] 8-K
[0001281895] SC 13D
[0001281895] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Maverick Capital Ltd Rocket Pharmaceuticals Inc [2025-04-14] 0.0
Wellington Management Group LLP Rocket Pharmaceuticals Inc [2024-02-08] 0.09
State Street Corp Rocket Pharmaceuticals Inc [2023-01-31] 5.05
Vanguard Group Inc Rocket Pharmaceuticals Inc [2022-02-10] 5.12
BlackRock Inc Rocket Pharmaceuticals Inc [2022-02-04] 5.2
Wellington Management Group LLP Rocket Pharmaceuticals Inc [2022-02-04] 5.42
Perceptive Advisors LLC Rocket Pharmaceuticals Inc [2021-02-16] 5.6
Price T Rowe Associates Inc /MD/ Rocket Pharmaceuticals Inc [2021-02-16] 5.7
Adage Capital Partners GP LLC Rocket Pharmaceuticals Inc [2019-01-17] 5.35
Boxer Capital LLC Rocket Pharmaceuticals Inc [2018-01-19] 0.0
RTW Investments LP Rocket Pharmaceuticals Inc [2018-01-16] 46.68
Tang Capital Partners LP Rocket Pharmaceuticals Inc [2018-01-16] 8.1
Opaleye Management Inc Inotek Pharmaceuticals Corp [2017-10-06] 11.0
Adage Capital Partners GP LLC Inotek Pharmaceuticals Corp [2017-10-05] 5.55
BML Investment Partners LP Inotek Pharmaceuticals Corp [2017-09-20] 5.5
OrbiMed Advisors LLC Inotek Pharmaceuticals Corp [2017-02-13] 4.68
Great Point Partners LLC Inotek Pharmaceuticals Corp [2017-01-03] 5.07
Citadel Advisors LLC Inotek Pharmaceuticals Corp [2016-08-29] 6.5
Astrazeneca PLC Inotek Pharmaceuticals Corp [2016-02-16] 7.3
RS Investment Management Co LLC Inotek Pharmaceuticals Corp [2016-02-12] 6.0
Rho Ventures IV QP LP Inotek Pharmaceuticals Corp [2016-02-12] 9.9
Franklin Resources Inc Inotek Pharmaceuticals Corp [2016-02-09] 5.8
Prudential Financial Inc Inotek Pharmaceuticals Corp [2016-02-03] 7.3
Jennison Associates LLC Inotek Pharmaceuticals Corp [2016-02-03] 7.3
BlackRock Inc Inotek Pharmaceuticals Corp [2016-01-28] 6.5
Point72 Asset Management LP Inotek Pharmaceuticals Corp [2015-08-24] 2.4
Polygon Management Ltd Inotek Pharmaceuticals Corp [2015-08-03] 6.372
Devon Park BioVentures LP Inotek Pharmaceuticals Corp [2015-03-05] 20.42
Care Capital III LLC Inotek Pharmaceuticals Corp [2015-03-05] 0.6
Form 3/4/5 Filer 2011 - 2025
Wilson Martin
Rocket Pharmaceuticals Inc
Militello John
Schwartz Jonathan David
Shah Gaurav
Stevens Christopher James
Southwell David P
Wong Roderick
Pratumsuwan Piratip
Granadillo Pedro P
Dolsten Mikael
Makker Gotham
Malik Fady Ibraham
Boess Carsten
Bjork Elisabeth
Ondrey Aaron
Patel Kinnari
Chaudhuri Sarbani
RTW Investments LP
White Mark Andrew
Woods Keith
Yalamanchi Naveen
Garcia-Parada Carlos
Alam Kamran
Batchelder Brian
Ritter Dale
Machado Patrick
Barberich Timothy J
Howes Paul G
Phillips Gary M.
Carroll J Martin
Spivey Richard N.
Baumgartner Rudolf A
Devon Park Associates, LLC
Devon Park BioVentures LP
Devon Park Associates, L.P.
McVicar William K.
Rho Ventures IV Holdings LLC
Rho Ventures IV-A, L.P.
Kantesaria Devang
Vogelbaum Martin
Harel Ittai
Karabelas Argeris N
Peimer Isai
Care Capital III LLC
Care Capital Offshore Investments III LP
Care Capital Investments III L.P.
Care Capital Investments II LP
Care Capital Offshore Investments II LP
Care Capital II LLC
MedImmune Ventures, Inc.
Pitango V.C. Fund IV, L.P.
Pitango Venture Capital Fund IV, L.P.
Pitango G.C. Capital Holdings Ltd.
Pitango Venture Capital Principals Fund IV, L.P.
Rho Capital Partners Verwaltungs GmbH
Rho Management Ventures IV LLC
Leschly Mark
Ruch Joshua
Rho Ventures IV QP LP
Rho Ventures IV LP
Rho Ventures IV GmbH & Co Beteiligungs KG
Kairouz Habib
Form 13F Holdings
Firm Period DFND Voting Shares
RTW Investments LP [2025-06-30] SOLE 17,687,772 17,687,772
Maverick Capital Ltd [2025-06-30] SOLE 8,363,813 8,363,813
BlackRock, Inc. [2025-06-30] SOLE 7,158,020 7,428,676
Vanguard Group Inc [2025-06-30] SOLE 0 5,958,370
Suvretta Capital Management LLC [2025-06-30] SOLE 4,143,333 4,143,333
MPM BioImpact LLC [2025-06-30] SOLE 3,903,081 3,903,081
Morgan Stanley [2025-06-30] DFND 2,954,245 3,169,036
Millennium Management LLC [2025-06-30] SOLE 2,348,837 2,348,837
Geode Capital Management LLC [2025-06-30] DFND 2,030,891 2,030,891
Newtyn Management LLC [2025-06-30] SOLE 2,000,000 2,000,000
State Street Corp [2025-06-30] DFND 1,738,894 1,943,690
Two Sigma Investments LP [2025-06-30] SOLE 1,725,360 1,725,360
ProSight Management LP [2025-06-30] SOLE 1,580,588 1,580,588
Goldman Sachs Group Inc [2025-06-30] DFND 1,574,773 1,575,468
Qube Research & Technologies Ltd [2025-06-30] SOLE 1,548,262 1,548,262
Two Sigma Advisers LP [2025-06-30] SOLE 1,432,306 1,490,251
JPMorgan Chase & Co [2025-06-30] DFND 1,127,212 1,205,841
Toronto Dominion Bank [2025-06-30] DFND 0 1,100,000
Price T Rowe Associates Inc /MD/ [2025-06-30] SOLE 1,016,849 1,016,849
D. E. Shaw & Co., Inc. [2025-06-30] DFND 992,825 992,825
Tang Capital Management LLC [2025-06-30] OTR 0 850,000
UBS Group AG [2025-06-30] DFND 811,308 836,508
AQR Capital Management LLC [2025-06-30] DFND 658,719 754,820
Susquehanna International Group LLP [2025-06-30] OTR 152,238 726,138
Cubist Systematic Strategies, LLC [2025-06-30] DFND 0 718,781
Northern Trust Corp [2025-06-30] DFND 687,829 688,689
Woodline Partners LP [2025-06-30] SOLE 652,865 652,865
Nuveen, LLC [2025-06-30] DFND 638,515 638,515
Federated Hermes Inc [2025-06-30] DFND 624,303 624,303
Charles Schwab Investment Management Inc [2025-06-30] SOLE 614,761 614,761
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com